Ascendis Health Limited (JSE:ASC)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc 92.00
0.00 (0.00%)
At close: Nov 28, 2025
Ascendis Health Income Statement
Financials in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | - | 1,472 | 1,535 | 1,559 | 1,825 | Upgrade
|
| Revenue Growth (YoY) | - | -4.13% | -1.54% | -14.57% | -17.14% | Upgrade
|
| Cost of Revenue | - | 886.86 | 930.91 | 889.4 | 1,066 | Upgrade
|
| Gross Profit | - | 585.18 | 604.53 | 670.05 | 759.13 | Upgrade
|
| Selling, General & Admin | 29.62 | 450.48 | 579.98 | 623.77 | 740.79 | Upgrade
|
| Other Operating Expenses | 9.19 | 115.65 | 166.42 | 113.14 | 142.79 | Upgrade
|
| Operating Expenses | 38.81 | 577.62 | 749.63 | 736.91 | 883.58 | Upgrade
|
| Operating Income | -38.81 | 7.56 | -145.1 | -66.86 | -124.45 | Upgrade
|
| Interest Expense | -8.54 | -12.48 | -62.47 | -453.91 | -1,064 | Upgrade
|
| Interest & Investment Income | 16.42 | 4.27 | 6.34 | 4.38 | 3.52 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 7.4 | Upgrade
|
| Other Non Operating Income (Expenses) | 15.12 | 2.19 | -2.47 | -28.42 | -18.82 | Upgrade
|
| EBT Excluding Unusual Items | -15.8 | 1.54 | -203.7 | -544.81 | -1,197 | Upgrade
|
| Impairment of Goodwill | - | - | - | -169.8 | -85.95 | Upgrade
|
| Gain (Loss) on Sale of Investments | 71.88 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -39.98 | 85.2 | 82.76 | 0.28 | 0.45 | Upgrade
|
| Asset Writedown | - | -28.92 | -128.81 | - | 0 | Upgrade
|
| Legal Settlements | - | - | - | - | 6.82 | Upgrade
|
| Other Unusual Items | -7.66 | -17.45 | -34.85 | -81.06 | -270.93 | Upgrade
|
| Pretax Income | 8.44 | 40.37 | -284.61 | -795.39 | -1,546 | Upgrade
|
| Income Tax Expense | -2.84 | -1.2 | 1.64 | -37.3 | 108.68 | Upgrade
|
| Earnings From Continuing Operations | 11.28 | 41.57 | -286.24 | -758.09 | -1,655 | Upgrade
|
| Earnings From Discontinued Operations | - | 15.72 | 361.56 | 1,208 | 599.9 | Upgrade
|
| Net Income to Company | 11.28 | 57.29 | 75.32 | 450.15 | -1,055 | Upgrade
|
| Minority Interest in Earnings | - | - | - | -0.95 | -35.84 | Upgrade
|
| Net Income | 11.28 | 57.29 | 75.32 | 449.2 | -1,091 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 0 | - | - | - | Upgrade
|
| Net Income to Common | 11.28 | 57.29 | 75.32 | 449.2 | -1,091 | Upgrade
|
| Net Income Growth | -80.32% | -23.94% | -83.23% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 626 | 626 | 606 | 480 | 481 | Upgrade
|
| Shares Outstanding (Diluted) | 626 | 626 | 606 | 480 | 481 | Upgrade
|
| Shares Change (YoY) | - | 3.27% | 26.35% | -0.35% | 0.83% | Upgrade
|
| EPS (Basic) | 0.02 | 0.09 | 0.12 | 0.94 | -2.27 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.09 | 0.12 | 0.94 | -2.27 | Upgrade
|
| EPS Growth | -80.32% | -26.35% | -86.73% | - | - | Upgrade
|
| Free Cash Flow | -12.38 | -45.2 | -176.11 | -149.14 | 607.91 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.07 | -0.29 | -0.31 | 1.26 | Upgrade
|
| Gross Margin | - | 39.75% | 39.37% | 42.97% | 41.59% | Upgrade
|
| Operating Margin | - | 0.51% | -9.45% | -4.29% | -6.82% | Upgrade
|
| Profit Margin | - | 3.89% | 4.91% | 28.80% | -59.76% | Upgrade
|
| Free Cash Flow Margin | - | -3.07% | -11.47% | -9.56% | 33.30% | Upgrade
|
| EBITDA | -38.78 | 51.13 | -86.9 | -20.87 | -80.12 | Upgrade
|
| EBITDA Margin | - | 3.47% | -5.66% | -1.34% | -4.39% | Upgrade
|
| D&A For EBITDA | 0.03 | 43.57 | 58.2 | 45.98 | 44.33 | Upgrade
|
| EBIT | -38.81 | 7.56 | -145.1 | -66.86 | -124.45 | Upgrade
|
| EBIT Margin | - | 0.51% | -9.45% | -4.29% | -6.82% | Upgrade
|
| Advertising Expenses | - | 53.38 | 51.76 | 32.32 | 65.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.